Gammaplex Purple Book BLA 125329

BLA number
125329
Proprietary names
Gammaplex
Proper names
Immune Globulin Intravenous (Human)
Applicant
Bio Products Laboratory Limited
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001GammaplexImmune Globulin Intravenous (Human)351(a)10G/200MLInjectionIntravenousSingle-Dose VialDiscLicensed2009-09-17
002GammaplexImmune Globulin Intravenous (Human)351(a)2.5G/50MLInjectionIntravenousSingle-Dose VialDiscLicensed2009-09-17
003GammaplexImmune Globulin Intravenous (Human)351(a)5G/100MLInjectionIntravenousSingle-Dose VialDiscLicensed2009-09-17
004GammaplexImmune Globulin Intravenous (Human)351(a)20G/400MLInjectionIntravenousSingle-Dose VialDiscLicensed2014-02-07
005GammaplexImmune Globulin Intravenous (Human)351(a)5G/50MLInjectionIntravenousSingle-Dose VialRxLicensed2017-02-06
006GammaplexImmune Globulin Intravenous (Human)351(a)10G/100MLInjectionIntravenousSingle-Dose VialRxLicensed2017-02-06
007GammaplexImmune Globulin Intravenous (Human)351(a)20G/200MLInjectionIntravenousSingle-Dose VialRxLicensed2017-02-06

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2025-06-01U001Gammaplex351(a)DiscBio Products Laboratory Limited
2025-06-01U003Gammaplex351(a)DiscBio Products Laboratory Limited
2025-06-01U004Gammaplex351(a)DiscBio Products Laboratory Limited
2024-08-01U001Gammaplex351(a)RxBio Products Laboratory Limited
2024-08-01U002Gammaplex351(a)DiscBio Products Laboratory Limited
2024-08-01U003Gammaplex351(a)RxBio Products Laboratory Limited
2024-08-01U004Gammaplex351(a)RxBio Products Laboratory Limited
2024-08-01U005Gammaplex351(a)RxBio Products Laboratory Limited
2024-08-01U006Gammaplex351(a)RxBio Products Laboratory Limited
2024-08-01U007Gammaplex351(a)RxBio Products Laboratory Limited
2023-07-01U001Gammaplex351(a)RxBio Products Laboratory
2023-07-01U002Gammaplex351(a)DiscBio Products Laboratory
2023-07-01U003Gammaplex351(a)RxBio Products Laboratory
2023-07-01U004Gammaplex351(a)RxBio Products Laboratory
2023-07-01U005Gammaplex351(a)RxBio Products Laboratory
2023-07-01U006Gammaplex351(a)RxBio Products Laboratory
2023-07-01U007Gammaplex351(a)RxBio Products Laboratory
2021-05-01U001Gammaplex351(a)RxBio Products Laboratory
2021-05-01U002Gammaplex351(a)DiscBio Products Laboratory
2021-05-01U003Gammaplex351(a)RxBio Products Laboratory
2021-05-01U004Gammaplex351(a)RxBio Products Laboratory
2020-08-01R001Gammaplex351(a)RxBio Products Laboratory
2020-08-01R002Gammaplex351(a)DiscBio Products Laboratory
2020-08-01R003Gammaplex351(a)RxBio Products Laboratory
2020-08-01R004Gammaplex351(a)RxBio Products Laboratory

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2025-06-01001Gammaplex351(a)DiscLicensed2009-09-17
2025-06-01003Gammaplex351(a)DiscLicensed2009-09-17
2025-06-01004Gammaplex351(a)DiscLicensed2014-02-07
2023-07-01004Gammaplex351(a)RxLicensed2014-02-07
2023-07-01005Gammaplex351(a)RxLicensed2017-02-06
2023-07-01006Gammaplex351(a)RxLicensed2017-02-06
2023-07-01007Gammaplex351(a)RxLicensed2017-02-06
2020-08-01001Gammaplex351(a)RxLicensed2009-09-17
2020-08-01002Gammaplex351(a)DiscLicensed2009-09-17
2020-08-01003Gammaplex351(a)RxLicensed2009-09-17
2020-08-01004Gammaplex351(a)RxLicensed2017-02-06